News Release: July 24, 2025
AVBN (Azobis(4-cyanovaleric acid)) Price, Production, and Global Market Developments in 2025
AVBN (Azobis(4-cyanovaleric acid) price trend and production News
AVBN (Azobis(4-cyanovaleric acid)) Price Trend in the Past Five Years and Factors Impacting Price Movements
Over the past five years, the AVBN (Azobis(4-cyanovaleric acid)) price trend has demonstrated a fluctuating pattern shaped by numerous global and regional dynamics. In 2020, the AVBN price was approximately $5,200/MT. At the time, supply-side constraints caused by disruptions in raw material procurement from China contributed to a slight uptick in global prices. The pandemic’s impact further intensified challenges around production continuity and logistics, pushing the price to $5,500/MT by the end of 2020.
The year 2021 saw a temporary stabilization in prices, with AVBN hovering around $5,450/MT in Q1 and reaching $5,600/MT by Q4, as the global supply chain gradually resumed normalcy. A surge in demand from polymer and pharmaceutical industries contributed to moderate price growth. However, these gains were short-lived, as in 2022, geopolitical tensions and rising energy costs drove the AVBN (Azobis(4-cyanovaleric acid)) price to $5,950/MT in mid-year before correcting slightly to $5,700/MT by the year-end. The increase in natural gas and crude oil prices had a direct impact on upstream feedstocks, making production costlier for AVBN producers.
In 2023, a significant price dip was recorded. With oversupply from Asia and reduced purchasing from Europe due to regulatory tightening, prices dropped from $5,700/MT in Q1 to $5,200/MT by Q4. Despite growing AVBN (Azobis(4-cyanovaleric acid)) sales volume in North America, it was insufficient to balance the global market’s downward pressure.
Entering 2024, AVBN prices slightly recovered to $5,350/MT due to improved production efficiency and strategic inventory drawdowns. However, margins remained tight as downstream industries hesitated to expand purchases amid uncertain macroeconomic conditions. Environmental regulation changes in the EU also contributed to fluctuating AVBN production volumes.
By early 2025, AVBN (Azobis(4-cyanovaleric acid)) price news highlighted steady recovery supported by reduced manufacturing overcapacity in China and renewed demand from coatings and adhesives sectors. As of Q1 2025, the global average stood at $5,650/MT. Factors positively influencing this trend included reduced energy input costs, steady AVBN (Azobis(4-cyanovaleric acid)) production ramp-up in the U.S., and favorable foreign trade dynamics in South Korea and Japan.
Raw material availability, shifts in production geography, environmental policies, and downstream demand remain the core drivers affecting AVBN (Azobis(4-cyanovaleric acid)) price trend globally. In 2025, the trend is gradually leaning toward recovery, albeit with controlled growth.
AVBN (Azobis(4-cyanovaleric acid)) Price Trend Quarterly Update in $/MT (2025)
- Q1 2025: $5,650/MT
- Q2 2025: $5,725/MT
- Q3 2025 (Estimated): $5,800/MT
- Q4 2025 (Forecast): $5,850/MT
These estimates point to a steady quarter-over-quarter rise in AVBN (Azobis(4-cyanovaleric acid)) price trend, driven by improved market balance and growth in sales volume from specialty chemical and pharmaceutical segments.
Global AVBN (Azobis(4-cyanovaleric acid)) Import-Export Business Overview
The global AVBN (Azobis(4-cyanovaleric acid)) import-export landscape in 2025 is undergoing substantial transformation due to trade realignments, environmental policy shifts, and diversified production capacities. Countries that were once heavily reliant on AVBN imports are now attempting to localize production to minimize dependency risks, while exporters are focusing on market-specific customization and regulatory alignment.
China continues to be the leading AVBN exporter in 2025, accounting for more than 40% of global exports. However, stricter environmental regulations and rising production costs have caused many Chinese manufacturers to explore joint ventures overseas. Export volumes to the European Union have dipped due to compliance challenges, but shipments to Southeast Asia and Latin America have surged, creating new revenue streams.
India, meanwhile, has emerged as a rising exporter in the AVBN market. With robust government support, improved manufacturing clusters, and competitive pricing, Indian manufacturers have increased their AVBN (Azobis(4-cyanovaleric acid)) sales volume significantly in the first half of 2025. Exports to the Middle East and Eastern Europe have grown at double-digit rates, with average export prices standing at $5,700/MT.
The United States, although a key importer, has ramped up its domestic AVBN (Azobis(4-cyanovaleric acid)) production in recent quarters. The 2025 Q2 commissioning of two new AVBN production plants in Texas and Louisiana is expected to reduce import dependence by at least 20% by the end of the year. The U.S. import price averaged $5,850/MT in Q2 2025, slightly above the global average due to higher quality specifications demanded by domestic end-users in pharmaceuticals and biomedical polymers.
Japan and South Korea are strategic importers with niche usage in electronics and coatings. Both countries have entered into long-term contracts with Indian and Chinese suppliers to stabilize pricing and supply. As of mid-2025, South Korean importers reported AVBN purchase prices averaging $5,730/MT, while Japan’s rate hovered around $5,750/MT.
Germany, France, and the Netherlands remain the largest importers within the EU. Despite facing challenges from REACH regulations, European companies have shifted sourcing to certified suppliers in Asia. Imports have become more selective, prioritizing sustainable production certifications and REACH-compliant specifications. German import volumes have dropped 7% year-over-year in H1 2025, while prices remained firm around $5,800/MT.
Brazil and Mexico are gaining importance as import destinations. With growing demand in water treatment chemicals and coatings, Latin America has seen a 15% increase in AVBN (Azobis(4-cyanovaleric acid)) imports in 2025 compared to the previous year. Average import prices in the region were approximately $5,670/MT in Q2.
On the export front, manufacturers in Southeast Asia, particularly Malaysia and Thailand, are exploring AVBN markets in Africa and Eastern Europe. AVBN (Azobis(4-cyanovaleric acid)) news reports in May 2025 confirmed a substantial export contract between a Thai supplier and a major South African coatings company, aimed at delivering over 300 MT annually for the next three years.
The AVBN (Azobis(4-cyanovaleric acid)) sales volume is expected to grow 8–10% year-over-year in 2025, supported by rising applications in adhesives, biomedical polymers, and specialty resins. However, logistics bottlenecks, particularly around key ports in Asia and disruptions due to shipping cost volatility, continue to present risks to stable trade flow.
In conclusion, the global AVBN (Azobis(4-cyanovaleric acid)) import-export structure in 2025 is characterized by diversification, investment in local capacity, and increasing regionalization of trade partnerships. The industry is witnessing a transition toward long-term, strategically aligned contracts that secure both pricing and availability, supported by an uptick in environmentally sustainable production practices.
For further data insights and in-depth analysis, click here to request a sample: https://datavagyanik.com/reports/avbn-azobis4-cyanovaleric-acid-market-size-production-sales-average-product-price-market-share-import-vs-export/
AVBN (Azobis(4-cyanovaleric acid)) Production Trends by Geography
In 2025, the global production landscape of AVBN (Azobis(4-cyanovaleric acid)) is marked by regional specialization, investment in technological advancements, and environmentally conscious manufacturing practices. The key geographies contributing to the production of AVBN include China, India, the United States, Japan, Germany, and South Korea. Each region exhibits unique production trends driven by raw material availability, government policies, demand fluctuations, and export capabilities.
China remains the world’s largest producer of AVBN, accounting for nearly 45% of global production in 2025. Chinese manufacturers benefit from vertical integration, proximity to raw material suppliers, and cost-effective labor. The domestic AVBN industry in China has seen recent investments in automation and emission control technologies, in response to stricter environmental regulations. These upgrades have helped maintain competitiveness while ensuring sustainability compliance for exports, especially to Europe and North America. Production is concentrated in provinces such as Jiangsu and Zhejiang, where chemical industrial parks have robust infrastructure.
India has emerged as a major production hub in Asia, second only to China. Supported by favorable government schemes for specialty chemicals, India’s AVBN production capacity grew by over 20% in the past year alone. Gujarat and Maharashtra have become the epicenters of AVBN manufacturing due to their proximity to ports, logistics advantages, and established chemical zones. Indian producers are increasingly focused on meeting EU and US regulatory standards, allowing them to expand their export footprint while catering to growing domestic demand from pharmaceuticals and advanced materials industries.
The United States is witnessing a strategic revival in AVBN production as part of its reshoring and industrial resilience strategy. In 2025, two new AVBN manufacturing facilities became operational in Texas and Louisiana, significantly reducing dependence on imports. These plants are leveraging cleaner technologies, digitized operations, and efficient waste management systems. Production in the U.S. is primarily geared toward serving high-value applications in biomedical research and specialty polymers, which demand consistent product quality and regulatory compliance. The trend reflects a broader move toward localized manufacturing in critical chemical sectors.
Japan and South Korea are prominent niche producers of AVBN, focusing on ultra-high-purity grades required in electronics, semiconductor chemicals, and high-end coatings. Although their overall production volumes are lower compared to China or India, both countries excel in producing AVBN tailored to stringent technical specifications. Japan, in particular, relies on precision synthesis methods and maintains a reputation for consistency and purity. South Korea, meanwhile, is investing in green chemistry initiatives to reduce the environmental footprint of its AVBN manufacturing processes.
Germany leads AVBN production in Europe, albeit on a smaller scale. The focus here is on quality, compliance, and innovation. German producers are closely aligned with the EU’s sustainability goals and are developing bio-based or low-emission AVBN alternatives. The production facilities are typically located in regions such as North Rhine-Westphalia and Bavaria, supported by advanced R&D infrastructure and regulatory frameworks.
Other Emerging Players: Southeast Asia, especially Thailand and Malaysia, is beginning to scale AVBN production to cater to regional demand in coatings, adhesives, and resins. While volumes remain modest, local producers are targeting niche markets and entering into long-term contracts with African and Middle Eastern countries.
In summary, the global AVBN (Azobis(4-cyanovaleric acid)) production scene in 2025 is geographically diverse and technologically evolving. Asia continues to lead in volume, North America is investing in self-reliance, and Europe is focusing on sustainable innovation. These trends reflect the growing strategic importance of AVBN in modern industrial applications.
AVBN (Azobis(4-cyanovaleric acid)) Market Segmentation
Key Market Segments:
- By Application:
- Polymerization Initiators
- Coatings and Adhesives
- Biomedical Materials
- Water Treatment Chemicals
- Specialty Chemicals
- By End-use Industry:
- Pharmaceuticals
- Electronics
- Construction
- Automotive
- Research & Development
- By Purity Grade:
- Standard Grade
- High Purity Grade
- Ultra High Purity Grade
- By Form:
- Powder
- Granules
- Aqueous Solution
- By Geography:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Explanation of Leading Segments
The AVBN (Azobis(4-cyanovaleric acid)) market in 2025 is characterized by diversified applications and evolving demand across various end-use industries. Among all segments, the polymerization initiators segment continues to dominate global consumption. AVBN is a preferred thermal initiator in free radical polymerization due to its controlled decomposition rate and low nitrogen emission. This makes it highly suitable for manufacturing acrylic polymers, resins, and functional polymers used across coatings, packaging, and adhesive applications.
Within the coatings and adhesives application segment, demand for AVBN has been rising in sectors requiring low VOC (volatile organic compound) solutions. AVBN’s ability to initiate polymerization at moderate temperatures has enabled formulators to design environment-friendly and energy-efficient coating systems. This segment is seeing strong growth in the construction and automotive sectors, especially in Asia-Pacific and Latin America.
The biomedical materials segment is emerging as a high-growth area for AVBN. In 2025, several biotechnology firms across the U.S. and Europe are utilizing AVBN in controlled drug delivery systems, polymeric nanoparticles, and hydrogels. The high purity grades of AVBN required for these applications have driven demand for specialized production techniques and tight quality control standards.
In the pharmaceuticals industry, AVBN is used indirectly in the development of pharmaceutical-grade polymers. These polymers find applications in drug encapsulation, implantable devices, and bioresorbable materials. The demand from this industry is pushing producers to adhere to stricter GMP (Good Manufacturing Practice) guidelines and ensure consistent batch quality.
Research & development is another key segment that, while smaller in volume, plays a critical role in product innovation and material testing. Universities, startups, and specialty labs globally continue to utilize AVBN for experimental polymer synthesis and radical initiator behavior studies.
By purity grade, the standard grade AVBN dominates in terms of volume due to its extensive use in industrial applications like water treatment and construction polymers. However, the high and ultra-high purity grades are showing higher CAGR due to rising use in electronics, pharmaceuticals, and biomedical fields.
In terms of form, powder-based AVBN remains the preferred form due to ease of handling, better shelf life, and superior dosing accuracy in large-scale manufacturing environments. Granular AVBN is gaining some traction in automated production systems. Aqueous solutions are limited to niche applications but offer advantages in processes that require quick dispersion or dilution.
From a geographical perspective, Asia-Pacific leads both in production and consumption. China and India have developed strong internal demand for AVBN in coatings and adhesives, while also exporting to North America and Europe. The North American market is primarily consumption-driven, with focus on high-end applications in biomedical and pharmaceutical industries. Europe, while heavily import-dependent, is investing in sustainable AVBN variants and application-based innovations.
Latin America and the Middle East & Africa are nascent but rapidly growing regions, fueled by infrastructure development, automotive sector growth, and expanding chemical processing industries. These regions are increasingly being targeted by Asian producers due to competitive pricing and long-term growth prospects.